VAD-based regimens as primary treatment for multiple myeloma
Author:
Publisher
Wiley
Subject
Hematology
Reference17 articles.
1. Chemotherapy for multiple myeloma
2. A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients
3. Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.
4. Progress in the treatment of plasma cell myeloma?
5. Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
Cited by 251 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aiming for the cure in myeloma: Putting our best foot forward;Blood Reviews;2023-11
2. Pretransplant Determinants of Outcome in Patients with Myeloma Undergoing Autologous Transplantation in Lower Resource Settings;European Medical Journal;2021-06-17
3. Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B‐lymphoblastic leukaemia: Ma‐Spore ALL 2010 study;British Journal of Clinical Pharmacology;2020-12-23
4. Are triplet therapies really living up to their hype as the “standard of care” for multiple myeloma and what else is needed?;Expert Review of Hematology;2019-07-16
5. Short-Course Lenalidomide Plus Low-Dose Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma—A Single-Centre Pragmatic Study;Current Oncology;2017-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3